Files

668397.pdf (270.56 KB)

Document type

Article

Version

Published version

Publication date

2016-09

Publication license

cc-by-nc (c) Darbà, Josep et al., 2016
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/107753

A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.2147/CEOR.S111453

Abstract

To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...

Subject

Administració de medicaments, Asma, Malalties pulmonars obstructives cròniques, Tractament tèrmic, Economia de la salut

Subject (English)

Administration of drugs, Asthma, Chronic obstructive pulmonary diseases, Heat treatment, Medical economics

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep, et al. A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions. Clinicoeconomics and Outcomes Research. 2016. Vol. 8, num. 435-444. ISSN 1178-6981. [consulted: 6 of June of 2026]. Available at: https://hdl.handle.net/2445/107753

Export metadata

JSON - METS

Share record